Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according ...